Re-Exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

This study is ongoing, but not recruiting participants.

Study NCT00675103 Information provided by Savient Pharmaceuticals

First Received: May 6, 2008 Last Updated: October 27, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)